Cannabis Use Disorder: Recognizing the Signs and Finding Effective Treatment
Cannabis use can become difficult to control, even when a person wants to cut back or is experiencing problems at home, school, work, or in relationships. That pattern is known as cannabis use disorder (CUD).
CUD is a medical condition—not a moral failing—and it can affect people who use cannabis in any form, including smoked, vaped, or edible products. Cannabis can produce both psychological and physical dependence, and withdrawal symptoms may make it harder to stop.
What is cannabis use disorder?
The DSM-5 framework for substance use disorders assesses whether cannabis use has led to a pattern of impaired control, disruption, risky behavior, or continued use despite harm. A clinician may diagnose CUD when at least two relevant symptoms occur within a 12-month period. Severity is classified as mild, moderate, or severe according to the number of criteria met.
Common signs include:
- Using more cannabis or using it for longer than intended
- Repeated unsuccessful attempts to reduce or stop
- Strong cravings or spending substantial time obtaining, using, or recovering from cannabis
- Failing to meet responsibilities at work, school, or home
- Giving up important social, occupational, or recreational activities
- Using cannabis in situations that create physical risks, such as before driving
- Continuing to use despite physical, psychological, social, or interpersonal problems
- Developing tolerance or needing more cannabis to achieve the same effect
- Experiencing withdrawal after reducing or stopping use
Having one of these experiences does not by itself establish a diagnosis. A health professional can evaluate the pattern, its effects on daily life, and any co-occurring medical or mental-health conditions.
Why does CUD develop?
There is no single cause. Risk reflects an interaction among biology, developmental stage, mental health, patterns of use, and social circumstances.
Frequent or near-daily use is associated with greater risk, particularly when products contain high concentrations of THC. Starting during adolescence may also increase vulnerability because the brain continues developing during the teenage years and young adulthood. A personal or family history of substance-use problems, stress, trauma, depression, anxiety, or post-traumatic stress disorder may add to that risk.
Some people use cannabis to manage insomnia, anxiety, pain, or other distress. Although it may provide short-term relief for some symptoms, relying on cannabis as the primary coping strategy can reinforce frequent use and delay treatment for the underlying problem. Co-occurring mental-health conditions should be assessed and treated alongside CUD.
Withdrawal and other health effects
Withdrawal is a recognized feature of problematic cannabis use. Symptoms can include irritability, anxiety, restlessness, reduced appetite, sleep problems, vivid dreams, depressed mood, headaches, sweating, and cravings. They are generally uncomfortable rather than medically dangerous, but they can contribute to relapse and may be more pronounced after heavy, prolonged use.
The Centers for Disease Control and Prevention’s overview of cannabis health effects notes that THC can affect memory, attention, coordination, decision-making, and reaction time. Heavy use may impair learning and attention for some time after the last use. Smoking cannabis can expose the lungs to harmful chemicals and is associated with respiratory symptoms such as cough and bronchitis.
Cannabis use is also associated with anxiety, depression, suicidal thoughts, and psychosis, although the relationships are complex and do not prove that cannabis alone causes every condition. The risk of psychosis appears particularly concerning among people who begin using at a younger age, use frequently, or already have relevant vulnerabilities. New or worsening paranoia, hallucinations, severe confusion, or suicidal thinking warrants prompt professional attention.
How CUD is treated
Treatment is tailored to the person’s goals, symptoms, age, health, and living situation. Some people work toward complete abstinence, while others initially focus on reducing use and addressing the problems associated with it.
Behavioral therapies
Evidence is strongest for psychosocial treatments, including:
- Cognitive behavioral therapy (CBT): Helps identify triggers, challenge unhelpful thinking, develop coping skills, and plan for high-risk situations.
- Motivational enhancement therapy (MET): Helps people explore ambivalence and strengthen their own reasons for changing their cannabis use.
- Contingency management: Uses structured rewards to reinforce treatment participation or cannabis-free goals. Research, including a 2024 systematic review, suggests that it can improve abstinence outcomes for some adults and adolescents.
- Family and social interventions: Can be especially useful for adolescents and young adults, whose recovery may depend on support at home and in their wider community.
A 2024 evidence synthesis of cannabis-use interventions found that CBT and MET can improve short-term cannabis-use frequency and dependence severity, although effects on long-term abstinence are less consistent. Treatment may require follow-up, relapse-prevention planning, and adjustments over time.
Medication and supportive care
There is currently no medication approved by the U.S. Food and Drug Administration specifically to treat CUD. Clinicians may nevertheless recommend short-term, symptom-focused care for withdrawal or prescribe treatment for co-occurring conditions when appropriate. No medication should be started or used to manage withdrawal without medical guidance.
Regular sleep, exercise, supportive relationships, stress-management skills, and a plan for avoiding triggers can complement formal treatment. Peer-support groups may also help some people, but they work best as one part of a broader, individualized recovery plan.
When to seek help
Consider speaking with a healthcare professional if cannabis use is difficult to control, interferes with responsibilities, causes conflict, or continues despite health or psychological consequences. A primary-care clinician, psychiatrist, psychologist, or addiction specialist can assess CUD and recommend treatment. In the United States, SAMHSA’s treatment locator provides referrals to licensed substance-use and mental-health services.
If someone is experiencing hallucinations, severe confusion, or thoughts of suicide, seek immediate help. Call or text 988 in the United States and Canada for crisis support, or call emergency services when there is an immediate danger.
